SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14520845
Source:
http://linkedlifedata.com/resource/pubmed/id/14520845
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0020538
,
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0205081
,
umls-concept:C0205082
,
umls-concept:C0376315
pubmed:issue
8
pubmed:dateCreated
2003-10-2
pubmed:abstractText
To evaluate efficacy and tolerance of a compound drug co-renitec combining an ACE inhibitor enalapril maleate and diuretic hydrochlorothiazide co-renitec taken for 16 weeks in essential hypertension (EH).
pubmed:language
rus
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/2984818R
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Enalapril
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrochlorothiazide
,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Chloride Symporter Inhibitors
pubmed:status
MEDLINE
pubmed:issn
0040-3660
pubmed:author
pubmed-author:ChazovaI EIE
,
pubmed-author:DmitrievV VVV
,
pubmed-author:KhanbalaevaM NMN
,
pubmed-author:KotkinaT ITI
,
pubmed-author:RatovaL GLG
pubmed:issnType
Print
pubmed:volume
75
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14520845-Aged
,
pubmed-meshheading:14520845-Albuminuria
,
pubmed-meshheading:14520845-Angiotensin-Converting Enzyme Inhibitors
,
pubmed-meshheading:14520845-Antihypertensive Agents
,
pubmed-meshheading:14520845-Blood Pressure
,
pubmed-meshheading:14520845-Diuretics
,
pubmed-meshheading:14520845-Drug Combinations
,
pubmed-meshheading:14520845-Enalapril
,
pubmed-meshheading:14520845-Female
,
pubmed-meshheading:14520845-Humans
,
pubmed-meshheading:14520845-Hydrochlorothiazide
,
pubmed-meshheading:14520845-Hypertension
,
pubmed-meshheading:14520845-Male
,
pubmed-meshheading:14520845-Middle Aged
,
pubmed-meshheading:14520845-Severity of Illness Index
,
pubmed-meshheading:14520845-Sodium Chloride Symporter Inhibitors
,
pubmed-meshheading:14520845-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
[Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
pubmed:publicationType
Journal Article
,
Clinical Trial
,
English Abstract